$ATEN
A10 Networks, Inc.

2015 Q2 Form 10-Q Financial Statement

#000158080815000036 Filed on August 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $47.54M $45.13M
YoY Change 5.33% 49.79%
Cost Of Revenue $11.60M $10.34M
YoY Change 12.2% 49.55%
Gross Profit $35.94M $34.79M
YoY Change 3.29% 49.86%
Gross Profit Margin 75.6% 77.09%
Selling, General & Admin $30.67M $29.51M
YoY Change 3.93% 51.94%
% of Gross Profit 85.33% 84.81%
Research & Development $13.67M $11.87M
YoY Change 15.18% 42.38%
% of Gross Profit 38.04% 34.11%
Depreciation & Amortization $2.200M $2.500M
YoY Change -12.0% 47.06%
% of Gross Profit 6.12% 7.19%
Operating Expenses $45.36M $35.52M
YoY Change 27.72% 9.09%
Operating Profit -$9.426M -$724.0K
YoY Change 1201.93% -92.25%
Interest Expense $104.0K $125.0K
YoY Change -16.8% 278.79%
% of Operating Profit
Other Income/Expense, Net -$320.0K -$263.0K
YoY Change 21.67% -63.27%
Pretax Income -$9.746M -$987.0K
YoY Change 887.44% -90.18%
Income Tax $231.0K $309.0K
% Of Pretax Income
Net Earnings -$9.977M -$1.296M
YoY Change 669.83% -87.31%
Net Earnings / Revenue -20.99% -2.87%
Basic Earnings Per Share -$0.16 -$0.02
Diluted Earnings Per Share -$0.16 -$0.02
COMMON SHARES
Basic Shares Outstanding 61.95M shares 59.71M shares
Diluted Shares Outstanding 61.95M shares 59.71M shares

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $96.20M $112.1M
YoY Change -14.18%
Cash & Equivalents $96.20M $112.1M
Short-Term Investments
Other Short-Term Assets $5.000M $4.400M
YoY Change 13.64%
Inventory $17.65M $18.54M
Prepaid Expenses
Receivables $46.17M $40.46M
Other Receivables $0.00 $0.00
Total Short-Term Assets $165.0M $175.5M
YoY Change -5.94%
LONG-TERM ASSETS
Property, Plant & Equipment $9.253M $11.95M
YoY Change -22.54%
Goodwill $72.00K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.484M $4.784M
YoY Change -6.27%
Total Long-Term Assets $13.74M $16.73M
YoY Change -17.89%
TOTAL ASSETS
Total Short-Term Assets $165.0M $175.5M
Total Long-Term Assets $13.74M $16.73M
Total Assets $178.8M $192.2M
YoY Change -6.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.089M $10.81M
YoY Change -43.65%
Accrued Expenses $20.90M $19.65M
YoY Change 6.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $72.26M $63.13M
YoY Change 14.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.425M $2.162M
YoY Change -34.09%
Total Long-Term Liabilities $1.425M $2.162M
YoY Change -34.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $72.26M $63.13M
Total Long-Term Liabilities $1.425M $2.162M
Total Liabilities $94.19M $79.82M
YoY Change 18.0%
SHAREHOLDERS EQUITY
Retained Earnings -$205.5M -$153.5M
YoY Change 33.91%
Common Stock $1.000K $1.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $84.59M $112.4M
YoY Change
Total Liabilities & Shareholders Equity $178.8M $192.2M
YoY Change -6.98%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$9.977M -$1.296M
YoY Change 669.83% -87.31%
Depreciation, Depletion And Amortization $2.200M $2.500M
YoY Change -12.0% 47.06%
Cash From Operating Activities $8.980M -$6.750M
YoY Change -233.04% 13.83%
INVESTING ACTIVITIES
Capital Expenditures -$910.0K -$1.770M
YoY Change -48.59% 48.74%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$910.0K -$1.770M
YoY Change -48.59% 48.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.570M -1.530M
YoY Change -267.97% -103.1%
NET CHANGE
Cash From Operating Activities 8.980M -6.750M
Cash From Investing Activities -910.0K -1.770M
Cash From Financing Activities 2.570M -1.530M
Net Change In Cash 10.64M -10.05M
YoY Change -205.87% -123.78%
FREE CASH FLOW
Cash From Operating Activities $8.980M -$6.750M
Capital Expenditures -$910.0K -$1.770M
Free Cash Flow $9.890M -$4.980M
YoY Change -298.59% 5.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
aten Costs Related To Initial Public Offering Included In Accounts Payable And Accrued Liabilities
CostsRelatedToInitialPublicOfferingIncludedInAccountsPayableAndAccruedLiabilities
1424000 USD
aten Costs Related To Initial Public Offering Included In Accounts Payable And Accrued Liabilities
CostsRelatedToInitialPublicOfferingIncludedInAccountsPayableAndAccruedLiabilities
0 USD
CY2014Q2 aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-138000 USD
aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-163000 USD
CY2015Q2 aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-216000 USD
aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-189000 USD
CY2015Q2 aten Minimum Ownership Threshold
MinimumOwnershipThreshold
0.05
aten Proceeds From Issuance Initial Public Offering Net
ProceedsFromIssuanceInitialPublicOfferingNet
122312000 USD
aten Proceeds From Issuance Initial Public Offering Net
ProceedsFromIssuanceInitialPublicOfferingNet
0 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001580808
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62420669 shares
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
dei Entity Registrant Name
EntityRegistrantName
A10 Networks, Inc.
dei Trading Symbol
TradingSymbol
ATEN
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8994000 USD
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6089000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
54003000 USD
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46165000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22435000 USD
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20897000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25744000 USD
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
30188000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
278349000 USD
CY2015Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
290088000 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3246000 USD
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2519000 USD
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10305000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10276000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11153000 shares
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11148000 shares
CY2014Q4 us-gaap Assets
Assets
186980000 USD
CY2015Q2 us-gaap Assets
Assets
178783000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
171341000 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
165046000 USD
CY2014Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
0 USD
CY2015Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
0 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20793000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112101000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91905000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96197000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
91308000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4292000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61377000 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62397000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61377000 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62397000 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2014Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10340000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20393000 USD
CY2015Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11601000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22387000 USD
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7410000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
14837000 USD
CY2015Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7909000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
14972000 USD
CY2014Q2 us-gaap Cost Of Services
CostOfServices
2930000 USD
us-gaap Cost Of Services
CostOfServices
5556000 USD
CY2015Q2 us-gaap Cost Of Services
CostOfServices
3692000 USD
us-gaap Cost Of Services
CostOfServices
7415000 USD
CY2014Q4 us-gaap Deferred Revenue
DeferredRevenue
57220000 USD
CY2015Q2 us-gaap Deferred Revenue
DeferredRevenue
65779000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
39256000 USD
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
45271000 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
17964000 USD
CY2015Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
20508000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4738000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4673000 USD
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2500000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-23418000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
309000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
514000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4700000 USD
CY2015Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2200000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4700000 USD
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14447000 USD
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13677000 USD
CY2015Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
28800000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M25D
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
6993000 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5531000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10894000 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5703000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13230000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
34792000 USD
us-gaap Gross Profit
GrossProfit
70484000 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
35935000 USD
us-gaap Gross Profit
GrossProfit
69166000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-987000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5884000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9746000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
231000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
293000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2105000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3048000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2644000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7723000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3632000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1619000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4610000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8559000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4265000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1861000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-6119000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
60000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3477000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
239000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-24000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2860000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-44000 USD
CY2014Q2 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
CY2015Q2 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
CY2014Q2 us-gaap Interest Expense
InterestExpense
125000 USD
us-gaap Interest Expense
InterestExpense
712000 USD
CY2015Q2 us-gaap Interest Expense
InterestExpense
104000 USD
us-gaap Interest Expense
InterestExpense
231000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10779000 USD
CY2015Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9846000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
20701000 USD
CY2015Q2 us-gaap Inventory Net
InventoryNet
17653000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
9922000 USD
CY2015Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
7807000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
90415000 USD
CY2015Q2 us-gaap Liabilities
Liabilities
94190000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
186980000 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
178783000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
70685000 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
72257000 USD
CY2014Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-5859000 USD
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-4013000 USD
CY2015Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1025000 USD
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1470000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
104817000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2626000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3791000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1811000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9718000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-1296000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6398000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-9977000 USD
us-gaap Net Income Loss
NetIncomeLoss
-23711000 USD
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1296000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7548000 USD
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9977000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23711000 USD
CY2014Q4 us-gaap Noncurrent Assets
NoncurrentAssets
11777000 USD
CY2015Q2 us-gaap Noncurrent Assets
NoncurrentAssets
10427000 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-263000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-875000 USD
us-gaap Operating Expenses
OperatingExpenses
75493000 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-320000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-420000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
35516000 USD
us-gaap Operating Expenses
OperatingExpenses
92164000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-724000 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
45361000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5009000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9426000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-22998000 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5434000 USD
CY2015Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4058000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4859000 USD
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4484000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1766000 USD
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1425000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
61000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-273000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3791000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1811000 USD
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
1150000 USD
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4732000 USD
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5031000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2658000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2626000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-153000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36524000 USD
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
39441000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10780000 USD
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9253000 USD
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
2891000 USD
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
1187000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
20000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11869000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23074000 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13671000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27980000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-181785000 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-205496000 USD
CY2014Q2 us-gaap Revenues
Revenues
45132000 USD
us-gaap Revenues
Revenues
90877000 USD
CY2015Q2 us-gaap Revenues
Revenues
47536000 USD
us-gaap Revenues
Revenues
91553000 USD
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
34122000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
70539000 USD
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
33331000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
63847000 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
45132000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
90877000 USD
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
47536000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
91553000 USD
CY2014Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
11010000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
20338000 USD
CY2015Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
14205000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
27706000 USD
CY2014Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
23975000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
45538000 USD
CY2015Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
24962000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
49484000 USD
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3006000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4776000 USD
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
4005000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8638000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8818000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1066000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
702000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
408000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.13
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
21583000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11084000 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10420000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.18
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.10
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
15136000 USD
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
5358000 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
4.14
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
20871000 USD
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
9927000 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.06
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.59
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.51
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.84
CY2015Q2 us-gaap Share Price
SharePrice
6.44
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y3M25D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y5M21D
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
7536000 USD
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
869000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
370000 shares
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
96565000 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
84593000 USD
CY2014Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2554000 USD
CY2015Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
3162000 USD
CY2014Q2 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
0 USD
us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
-1150000 USD
CY2015Q2 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
0 USD
us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
0 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2200000 USD
CY2015Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2300000 USD
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59711000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36712000 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61945000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61690000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59711000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36712000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61945000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61690000 shares
us-gaap Year Founded
YearFounded
2004
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash, cash equivalents and accounts receivable. Our cash and cash equivalents are invested in high-credit quality financial instruments with banks and financial institutions. Management believes that the financial institutions that hold our cash and cash equivalents are financially sound and, accordingly, are subject to minimal credit risk. Such deposits may be in excess of insured limits provided on such deposits.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our accounts receivable are unsecured and represent amounts due to us based on contractual obligations of our customers. We mitigate credit risk in respect to accounts receivable by performing periodic credit evaluations of our customers to assess the probability of accounts receivable collection based on a number of factors, including past transaction experience with the customer, evaluation of their credit history, limiting the credit extended and review of the invoicing terms of the contract. We generally do not require our customers to provide collateral to support accounts receivable. </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant customers, including distribution channel partners and direct customers, are those which represent more than 10% of our total revenue for each period presented or our gross accounts receivable balance as of each respective balance sheet date.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Those estimates and assumptions affect revenue recognition and deferred revenue, allowance for doubtful accounts, sales return reserve, valuation of inventory, contingencies and litigation, and determination of fair value of stock-based compensation. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from management&#8217;s estimates.</font></div></div>

Files In Submission

Name View Source Status
0001580808-15-000036-index-headers.html Edgar Link pending
0001580808-15-000036-index.html Edgar Link pending
0001580808-15-000036.txt Edgar Link pending
0001580808-15-000036-xbrl.zip Edgar Link pending
aten-20150630.xml Edgar Link completed
aten-20150630.xsd Edgar Link pending
aten-20150630_cal.xml Edgar Link unprocessable
aten-20150630_def.xml Edgar Link unprocessable
aten-20150630_lab.xml Edgar Link unprocessable
aten-20150630_pre.xml Edgar Link unprocessable
aten-2015630x10q.htm Edgar Link pending
exhibit1012014equityincent.htm Edgar Link pending
exhibit3112015630.htm Edgar Link pending
exhibit3122015630.htm Edgar Link pending
exhibit3212015630.htm Edgar Link pending
exhibit3222015630.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending